Legend Biotech (LEGN) Debt Ratio (2021 - 2025)

Legend Biotech's Debt Ratio history runs 5 years deep, the most recent figure standing at 0.18 for Q4 2025.

• Quarterly Debt Ratio rose 2.06% year-over-year to 0.18 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.18 (up 2.06% YoY) and the FY2025 annual result came in at 0.18, up 2.06% from the prior year.
• Debt Ratio was 0.18 for Q4 2025 at Legend Biotech, up from 0.1 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.22 in Q1 2023 and bottomed at 0.0 in Q2 2021.
• A 5-year average of 0.15 and a median of 0.16 in 2024 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2022 — Debt Ratio soared 82.19% — and 2025, when it slumped 41.26%.
• Legend Biotech's Debt Ratio stood at 0.11 in 2021, then jumped by 82.19% to 0.2 in 2022, then declined by 22.37% to 0.15 in 2023, then rose by 18.5% to 0.18 in 2024, then gained by 2.06% to 0.18 in 2025.
• Business Quant data shows LEGN's Debt Ratio at 0.18 in Q4 2025, 0.1 in Q3 2025, and 0.18 in Q2 2025.